Fundraising FoxCerespir
New York, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into Cerespir
Sign up to see every warm intro you have to Cerespir
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cerespir team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pharmaceutical company developing novel approach to Alzheimer's disease
Founders & leadership
Cerespir was founded in 2013 by Daniel G. Chain.
DG
Daniel G. ChainFounder
AN
Adrian N. HobdenExecutiveAdrian N. Hobden established and led the Department of Genetics and Molecular Biology at Glaxo PLC, managing biotech partnerships and business development across the pharmaceutical industry. He founded Myriad Pharmaceuticals and scaled it to 220 employees, overseeing clinical development programs and a major placebo-controlled trial for an experimental Alzheimer's treatment.
Board
SJ
Samuel JesselsonBoard director
MJ
Michael JesselsonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2016
▶$500KraisedSep 2016 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adrian N. HobdenExecutive Officer, Director
- Daniel G. ChainExecutive Officer, Director
- Samuel JesselsonDirector
- Michael JesselsonDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Proceeds to insiders
- $135K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cerespir do?
- Pharmaceutical company developing novel approach to Alzheimer's disease
- Who founded Cerespir?
- Cerespir was founded by Daniel G. Chain in 2013.
- Who are Cerespir's investors?
- Cerespir's investors include Vedanta Capital.
- How much funding has Cerespir raised?
- Cerespir has disclosed $500K raised across 1 round.
- Where is Cerespir headquartered?
- Cerespir is headquartered in New York, US.